tiprankstipranks
BioVaxys Technology Bolsters Funds and Settles Debt
Company Announcements

BioVaxys Technology Bolsters Funds and Settles Debt

Story Highlights

BioVaxys Technology (TSE:BIOV) has released an update.

Don't Miss our Black Friday Offers:

BioVaxys Technology Corp. is poised to enhance its financial stability through a planned private placement aiming to raise CAD $500,000 and a debt settlement initiative to address up to CAD $733,600 in liabilities with common shares issuance. The funds from the private placement are intended for the company’s general working capital, facilitating advancements in its diverse immunotherapy platforms. Both the private placement and debt settlement are set to close by July 31st, 2024, conditional upon regulatory approvals and other customary closing requirements.

For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBioVaxys and SpayVac Boost Vaccine Production Capacity
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Joins US Vaccine Development Consortium
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Advances in Drug Delivery Market
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App